TLE3 and neoplasm: More specifically, we show that the TLE3 is enriched during the malignant alteration of melanocytes in human patient tumor samples, and we further present evidence that Tle3 promotes proliferation in murine B16 and human HMV-II melanoma cells by an HDAC activity-dependent mechanism.